These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29780148)

  • 1. Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide.
    Furukawa R; Homma H; Inoue T; Horiuchi H; Usui K
    Intern Med; 2018 Oct; 57(20):3047-3050. PubMed ID: 29780148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
    Okita Y; Narita Y; Miyakita Y; Ohno M; Nagai S; Shibui S
    Intern Med; 2012; 51(20):2967-71. PubMed ID: 23064578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
    Yaman E; Coskun U; Ozturk B; Buyukberber S; Kaya AO; Coskun O; Buyukberber N; Yildiz R; Benekli M
    J Clin Neurosci; 2009 Apr; 16(4):591-2. PubMed ID: 19201195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma".
    Gousias K; Kyritsis A
    J Clin Neurosci; 2010 Mar; 17(3):412. PubMed ID: 20079651
    [No Abstract]   [Full Text] [Related]  

  • 5. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature.
    Mohammadianpanah M; Shirazi M; Mosalaei A; Omidvari S; Ahmadloo N
    Clin Ther; 2007 Jun; 29(6):1161-5. PubMed ID: 17692730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
    Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
    Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis.
    Franklin C; Rooms I; Fiedler M; Reis H; Milsch L; Herz S; Livingstone E; Zimmer L; Schmid KW; Dittmer U; Schadendorf D; Schilling B
    Eur J Cancer; 2017 Nov; 86():248-256. PubMed ID: 29055840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients.
    Nagafuji K; Aoki K; Henzan H; Kato K; Miyamoto T; Eto T; Nagatoshi Y; Ohba T; Obama K; Gondo H; Harada M
    Bone Marrow Transplant; 2004 Nov; 34(10):909-14. PubMed ID: 15361907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
    Mitsumori T; Sueki Y; Kawashima I; Yamamoto T; Nozaki Y; Nakajima K; Kirito K
    Rinsho Ketsueki; 2014 Feb; 55(2):239-43. PubMed ID: 24598192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
    Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
    Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
    Held TK; Biel SS; Nitsche A; Kurth A; Chen S; Gelderblom HR; Siegert W
    Bone Marrow Transplant; 2000 Aug; 26(3):347-50. PubMed ID: 10967578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide-related infections: review of the literature.
    Kizilarslanoglu MC; Aksoy S; Yildirim NO; Ararat E; Sahin I; Altundag K
    J BUON; 2011; 16(3):547-50. PubMed ID: 22006764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report.
    Islam R; Isaacson BJ; Zickerman PM; Ratanawong C; Tipping SJ
    Am J Clin Oncol; 2002 Oct; 25(5):513-4. PubMed ID: 12393995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
    Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study.
    Trippoli S; Pelagotti F; Messori A; Vacca F; Vaiani M; Maltoni S
    Drugs R D; 2003; 4(5):285-91. PubMed ID: 12952497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
    Schwarzberg AB; Stover EH; Sengupta T; Michelini A; Vincitore M; Baden LR; Kulke MH
    Cancer Invest; 2007 Jun; 25(4):249-55. PubMed ID: 17612935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of cytomegalovirus infections in patients treated with immunosuppressive drugs for chronic inflammatory diseases].
    Tnani N; Massoumi A; Lortholary O; Soussan P; Prinseau J; Baglin A; Hanslik T
    Rev Med Interne; 2008 Apr; 29(4):305-10. PubMed ID: 18068874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus-induced haemorrhagic cystitis in a patient with neurogenic bladder.
    Basquiera AL; Calafat P; Parodi JM; De Diller AB; Zlocowski JC; Caeiro JP
    Scand J Infect Dis; 2003; 35(11-12):902-4. PubMed ID: 14723379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.